tecovirimat smallpox monkeypox
Selected indexed studies
- Monkeypox. (Lancet, 2023) [PMID:36403582]
- Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. (J Infect Public Health, 2023) [PMID:36801633]
- Monkeypox Virus Infections in Humans. (Clin Microbiol Rev, 2022) [PMID:36374082]
_Worker-drafted node — pending editorial review._
Connections
tecovirimat smallpox monkeypox is a side effect of
Sources
- Monkeypox. (2023) pubmed
- Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. (2023) pubmed
- Monkeypox Virus Infections in Humans. (2022) pubmed
- Mpox: Global epidemic situation and countermeasures. (2025) pubmed
- Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments. (2022) pubmed
- Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects. (2023) pubmed
- Tecovirimat. (2012) pubmed
- Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. (2024) pubmed
- Treatment and Vaccination for Smallpox and Monkeypox. (2024) pubmed
- Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox. (2023) pubmed